10/22/2025
United Health Group Under Federal Investigation
Follow CC Consulting & Credentialing Services for updates as they become available
UnitedHealth confirmed in late July 2025 that it is under a federal investigation by the U.S. Department of Justice (DOJ), involving both criminal and civil probes. 
• The investigations relate to its Medicare business, especially the privately-run Medicare Advantage (MA) plans. 
• Earlier media reports (e.g., by The Wall Street Journal) indicated a civil fraud investigation regarding how UnitedHealth records diagnoses in its MA plans, potentially to boost payments. 
• UnitedHealth stated it is cooperating with the DOJ, has been complying with formal requests, and has launched its own third-party review of certain internal practices (risk-coding, managed care practices, pharmacy services). 
• The company emphasised that audits by Centers for Medicare & Medicaid Services (CMS) show its practices “among the most accurate in the industry.” 
⸻
🚨🚨What is not yet clear
• The exact scope and nature of the criminal investigation: while there’s indication of a DOJ criminal-health-care-fraud unit probe, the precise allegations (which practices, which time periods, which specific subsidiaries or business units) have not been publicly detailed. 
• Whether UnitedHealth has received formal criminal charges at this point (as of available reporting). The company says it has begun complying with requests, but a formal indictment or resolution has not been publicly confirmed. 
• The potential financial and operational impact: while the stock dropped following reports of the investigation, the ultimate liability (fines, damages, business restrictions) remains speculative.
• Whether this investigation will affect specific MA plan enrollee care, provider contracts, or entail changes to how UnitedHealth handles diagnosis coding, provider relationships, etc.
⸻
🧐🧐Why this matters
• Medicare Advantage is a large and growing part of the U.S. Medicare system. If insurers are coding diagnoses at higher rates to obtain higher payments, that raises questions about cost to taxpayers, fairness in competition, and provider-incentives.
• UnitedHealth is one of the largest players in MA. So scrutiny of its practices could potentially lead to broader regulatory or industry-wide changes.
• For stakeholders (investors, providers, patients) the investigation introduces increased risk: regulatory, reputational, operational.
⸻
✅✅Quick timeline of key points
• Feb 2025: Media reports that the DOJ is investigating UnitedHealth’s MA diagnosis-coding practices. 
• May 2025: Reports of possible criminal probe, UnitedHealth stock dropped. 
• July 24, 2025: UnitedHealth publicly acknowledges investigation and cooperation with DOJ. 
• Earlier history: UnitedHealth also facing antitrust/merger scrutiny (for example, DOJ’s suit to block acquisition of Amedisys) which shows multiple regulatory fronts. 
⸻
⏰⏰What to watch next
• Watch for any formal charges from the DOJ: this could change the stakes considerably.
• Regulatory responses from CMS and HHS (Office of Inspector General, U.S. Department of Health & Human Services) – will they issue sanctions, change rules for MA plans?
• How UnitedHealth adjusts its business practices (coding-policies, provider incentives, audits) in response.
• Financial disclosures from UnitedHealth (SEC filings) about potential liabilities, reserves, business risk.
• Impact on beneficiaries / providers: will there be changes in how MA plans operate, provider payments, patient access
